Get 40% Off
💰 Buffett reveals a $6.7B stake in Chubb. Copy the full portfolio for FREE with InvestingPro’s Stock Ideas toolCopy Portfolios

Why Are Natus Medical Shares Trading Higher Today

Published 18/04/2022, 12:38
© Reuters.  Why Are Natus Medical Shares Trading Higher Today
NTUS
-

  • Natus Medical Inc (NASDAQ: NTUS) will be acquired by ArchiMed, an investment firm focused exclusively on the healthcare industry, for approximately $1.2 billion.
  • Natus shareholders will receive $33.50 in cash for each share, representing a 29% premium to the closing price of the company's common stock on April 14.
  • "The sale of Natus to ArchiMed will provide our shareholders with immediate and substantial cash value, as well as a compelling premium, and the Board has unanimously agreed that this transaction is in the best interests of our shareholders," said Joshua H. Levine, Chairman of Natus.
  • The transaction is expected to close in Q3 of 2022.
  • Under the terms of the merger agreement, Natus may solicit proposals from third parties for 30 days continuing through May 17, and in some instances, for 35 days continuing through May 22.
  • Natus also reported Q1 FY22 sales of $119.8 million, up 4.3% Y/Y.
  • During Q1, the company incurred $3.4 million of extraordinary supply chain costs associated with acquiring semiconductors.
  • The company ended the quarter with $84 million in cash and no debt.
  • Price Action: NTUS, which resumed trading after trading halt, is higher by 27.4% at $33.20 in pre-market on Monday's last check.

Read at Benzinga

Read the original article on Benzinga

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.